Abstract
The frequent zoonotic disease known as “bovine tuberculosis” is brought on by the Mycobacterium bovis bacteria, which can infect both people and animals. The aim of this review article is to provide an explanation of the etiology, history, epidemiology, pathogenesis, clinical symptoms, diagnosis, transmission, risk factors, public health importance, economic impact, treatment, and control of bovine tuberculosis. Primarily, bovine tuberculosis affects cattle, but other animals may also be affected. Bovine tuberculosis is present throughout the world, with the exception of Antarctica. Cattle that contract bovine tuberculosis might suffer from a persistent, crippling illness. In the early stages of the disease, there are no symptoms. The tuberculin test is the primary method for detecting bovine tuberculosis in cows. Depending on its localized site in the infected animal, M. bovis can be found in respiratory secretions, milk, urine, feces, vaginal secretions, semen, feces, and exudates from lesions (such as lymph node drainage and some skin lesions). This illness generally lowers cattle productivity and could have a negative financial impact on the livestock business, particularly the dairy industry. The most effective first-line anti-tuberculosis chemotherapy consists of isoniazid, ethambutol, rifampin, and streptomycin. Second-line drugs used against bovine tuberculosis include ethionamide, capreomycin, thioacetazone, and cycloserine. To successfully control and eradicate bovine tuberculosis, developed nations have implemented routine testing and culling of infected animals under national mandatory programs.
Keywords: Bovine tuberculosis, Cattle, Infectious disease, M. bovis, Public health
Introduction
For more than a century, members of the genus Mycobacterium have been the source of the infectious disease tuberculosis, which poses a serious threat to both human and animal health (Borham et al., 2022). Currently, this illness is the cause of more deaths than any other bacterial illness. Over 2 billion people, or one-third of the global population, are infected with this bacterium, and between 1.5 and 2 million people die from tuberculosis each year (Houben and Dodd, 2016). This illness is credited as being the primary cause of infectious disease-related deaths worldwide. There are three forms of tuberculosis, which affects different species: human, poultry, and bovine tuberculosis (Dhama et al., 2011; Bihon et al., 2021).
Bovine tuberculosis, due to Mycobacterium bovis, is a serious infectious disease that affects a wide range of domesticated and wild animals with grave economic and public health challenges (Kasir et al., 2023).
The frequent zoonotic disease known as “bovine tuberculosis” is brought on by the Mycobacterium bovis bacteria, which can infect both people and animals (Kasir et al., 2023). Livestock-transmitted bovine tuberculosis has grown to be a serious infectious disease that can cross species boundaries (Broughan et al., 2016). The development of granulomatous nodules known as tubercles, which are indicative of bovine tuberculosis, is largely dependent on the infection route (Palmer et al., 2022). Bovine tuberculosis is a global disease that affects the cattle-producing industry greatly economically. However, the requirement for pasteurization of milk, tuberculin testing of cow skin, and culling of diseased cattle has resulted in a dramatic drop in the incidence of human tuberculosis caused by M. bovis in developed countries (Palmer et al., 2012).
These bacteria can produce aerosolized droplets that infected animals can cough up or exhale, which susceptible animals or people can subsequently inhale (Hanif and Garcia-Contreras, 2012). The risk of exposure is highest in spaces that are enclosed, such as warehouses. The most typical way of transmission for veterinary professionals who treat sick animals as well as agricultural and livestock workers is inhaling droplets (Mohamed, 2019). Shared drinking troughs containing the saliva and other excrement of diseased animals increase the risk of infection amongst livestock (Bouchez-Zacria et al., 2018). Furthermore, adding animals frequently raises the risk of introducing disease and having a large animal population raises the risk of the disease spreading throughout the herd (Skuce et al., 2012).
According to estimates, culling losses from this disease can account for 30%–50% of the difference between dairy or beef cattle’s market value and their worth at slaughter (Pérez-Morote et al., 2020). A major contributing factor to zoonotic M. bovis infections in humans is the consumption of raw or unpasteurized animal products, inhalation of bacterium-containing droplets, and contact with diseased carcasses (Luciano and Roess, 2020). The precise incidence of M. bovis-caused bovine tuberculosis in humans is challenging to ascertain because of technological challenges in isolating the microbe. Given that people and animals coexist in the same environment and often live in rural regions, bovine tuberculosis in humans is becoming a bigger problem in emerging nations (Malama et al., 2013).
According to research, bovine tuberculosis is still prevalent in underdeveloped and developing nations, and M. bovis is thought to be the causative agent of 10%–15% of human tuberculosis cases (Getahun et al., 2020). There is a wide range of effects on M. bovis infection, and the risk of transmission of this disease is dependent on host, pathogen, and environmental factors (Allen et al., 2021). Mycobacterium bovis is thought to primarily infect cattle, despite the fact that the disease has been isolated from many other livestock and animal species so there is a risk of human transmission that could affect public health (Devi et al., 2021). The incidence and consequences of bovine tuberculosis may still be underestimated globally since many nations lack robust surveillance systems and epidemiological research is scarce (Luciano and Roess, 2020).
Interspecies disease transmission is among the least studied aspects of disease ecology. One of these pathogens is the causative agent of tuberculosis in cattle, M. bovis. The aim of this review article is to provide an explanation of the etiology, history, epidemiology, pathogenesis, clinical symptoms, diagnosis, transmission, risk factors, public health importance, economic impact, treatment, and control of bovine tuberculosis.
Etiology
Mycobacterium bovis serves as the etiological agent for bovine tuberculosis (Kasir et al., 2023). Mycobacterium bovis grows best in frozen tissue, but tissue preservatives such as sodium tetraborate prevent this bacterium from growing (Borham et al., 2022). This microbe is facultative intracellular, obligate aerobic, non-motile, and does not create spores. Its dimensions are 1–10 µm in length and 0.2–0.6 µm in breadth, and it takes 15–20 hours to generate (Nava-Vargas et al., 2021). The incubation time for M. bovis is 3 weeks. Mycobacterium bovis can endure for several months in the environment, particularly in conditions that are chilly, gloomy, and damp (Allen et al., 2021). The microbe’s survival period varies according on sunlight exposure, ranging from 18 to 332 days at 12°C to 24°C.
History
Since thousands of years ago, it has been known that numerous mammals are afflicted with tuberculosis. This disease is thought to be the leading cause of death in the past 200 years when weighed against other serious illnesses (Borham et al., 2022). The cause of tuberculosis in humans, Mycobacterium tuberculosis, was found by Koch in 1882 (Cambau and Drancourt, 2014). However, Smith distinguished M. bovis from M. tuberculosis in 1898 (Mitermite et al., 2023). The loss of productivity, sickness, and death caused by bovine tuberculosis, along with the possible zoonotic hazard, make it a highly significant economic concern (Rahman et al., 2020). Cost monitoring is also very important from an economic standpoint. Regional disease foci that are not thought to be free of bovine tuberculosis still persist in the US, Australia, and several European nations, despite the fact that the illness poses a significant threat in emerging nations (Fitzgerald and Kaneene, 2013). In addition, the cattle business in the UK continues to face significant challenges due to the widespread prevalence of bovine tuberculosis (Allen et al., 2018).
Epidemiology
Bovine tuberculosis is present throughout the world, with the exception of Antarctica (Ramos et al., 2020). Worldwide, more than 50 million cattle are likely exposed to bovine tuberculosis (Srinivasan et al., 2021). India has been noted to be a country with the largest infected herds worldwide with an estimated bovine tuberculosis prevalence of 7.3% among farm and dairy cattle (Ramanujam and Palaniyandi, 2023).
Although bovine tuberculosis was formerly widespread, management initiatives have eradicated or almost completely eradicated the illness in many nations’ livestock populations. According to current statistics, the following nations are free of bovine tuberculosis: Australia, Sweden, the Czech Republic, Norway, Austria, Switzerland, Luxembourg, Jamaica, Latvia, Slovakia, Iceland, Estonia, Canada, Lithuania, Finland, Barbados, Denmark, and Singapore (Humblet et al., 2009). There are initiatives in place to eradicate bovine tuberculosis in the United States, New Zealand, Japan, and several European nations (Borham et al., 2022). Though it can also infect other livestock including goats, sheep, and camels as well as wild animals such as civets, possums, and deer, bovine tuberculosis is still a serious infectious illness in some places where it affects cattle (Mohamed, 2019).
In underdeveloped nations with inadequate control efforts, this disease continues to pose a risk to public health and produces substantial economic challenges for the livestock industry (Little, 2019). In Africa, 82% of people and 85% of cattle reside in regions where bovine tuberculosis in cattle has been reported (Ghebremariam et al., 2016). The main causes of the spread of domestic ruminant populations and the variations in milk production within the African ecological zone are the reasons that are mentioned in relation to the dissemination of bovine tuberculosis in Africa (De Garine-Wichatitsky et al., 2013). This element may have a major impact on the spread of bovine tuberculosis, along with variations in the production strategies used to manage animals across the African continent, such as pastoralism, agro-pastoralism, mixed farming, and intense dairy farming (Renwick et al., 2007; Pokam et al., 2019).
There are significant regional variations in the prevalence of bovine tuberculosis within a nation. According to reports from South America, locations surrounding large towns with high concentrations of intense milk production are also home to the greatest incidences of bovine tuberculosis (Avila et al., 2018). Bovine tuberculosis prevalence has been reported to be highest in India (7.3 %), followed by Brazil (2.5 %), and China (2.4 %) (Gong et al., 2021; Rodrigues et al., 2022; Ramanujam and Palaniyandi, 2023).
In nations with advanced testing and control systems and a comprehensive set of surveillance and control methods to address cow-to-cow transmission, bovine tuberculosis is likely to be an infectious illness with a low incidence and apparent low transmission rate (Mandal et al., 2023). The primary reservoir for M. bovis is cattle (Palmer et al., 2012). Mycobacterium bovis infections primarily occur in humans who consume raw milk and dairy products, while they can also occur in the air (Ortiz et al., 2021). The most frequent M. bovis infection in children (Gallivan et al., 2015). This microorganism affects the tonsils and can cause digestive tract infections that lead to abdominal tuberculosis or “scrofula” or cervical lymphadenitis (Waters and Palmer, 2015). Mycobacterium bovis typically inhabits extrapulmonary sites in the intestines, kidneys, brain, and bones (Torres-Gonzalez et al., 2016).
Pathogenesis
Most of the bacilli stay in the upper respiratory tract after inhalation. Alveolar macrophages will breakdown any bacteria that make it into the alveoli. The high quantity of lipids that penetrate the cell walls and proliferate in macrophages makes tubercle bacilli resistant to phagocytosis (Kawka et al., 2023). Mycobacterium accumulation causes cell-mediated hypersensitivity and inflammatory foci. The cytokines released by activated macrophages cause tubercles, which are specific tissue lesions (Hossain and Norazmi, 2013). Avascular granulomas known as tubercles are composed of two zones: a peripheral zone containing lymphocytes and fibroblasts (epithelioid cells) and a central zone containing giant cells (Datta et al., 2016). The potential for illness to develop within the host is determined by the mycobacteria’s capacity to proliferate and survive inside macrophages. Phagosome-lysosome fusion is prevented, which allows macrophage organisms to survive and multiply at the initial infection site (Zhai et al., 2019).
Mycobacteria’s pathogenicity is based on their capacity to avoid phagocytic death, which is mostly brought on by components of their cell walls, such as: TDM is a surface glycolipid implicated in umbilical cord factor and serpentine growth in vitro; Suphatide is a sulfur-containing surface glycolipid that inhibits the fusion of phagosomes with lysosomes; bacteria’s produced cAMP may also help with this; lipoarabinomannan (LAM) heteropolysaccharide, which prevents interferron gamma (IFNã) from activating macrophages and causes them to release TNFá, which raises fever, and IL-10, which reduces T cell proliferation brought on by mycobacteria; and peptidoglycan, cell wall waxes, and other glycolipids are in charge of extra processes that draw antigen-presenting cells (Rahlwes et al., 2023).
Mycobacteria enter macrophages throughout the body and are discharged from them (Weiss and Schaible, 2015). The host’s immunological response to mycobacteria and the formation of lesions is aided by the waxy cell wall component mycolic acid. The host initiates a cell-mediated immune response by stimulating T cells and macrophages, which is followed by the development of granulomas and a delayed-type hypersensitivity reaction (Smith et al., 2021). Mycobacterium virulence is associated with several lipids that are absent from other bacterial species. Surface-bound mycobacterial lipids that can influence innate immunity include lipomannan (LM), LAM, phosphatidylinositol mannosides, umbilical cord factors trehalose mono- and (TMM and TDM), and phthiocerol dimycocerosates (Ghazaei, 2018). Monomycolyl glycerol, one of the recently discovered lipids, has been demonstrated to alter hypervirulence and host immunity (Andersen et al., 2009).
These germs are absorbed by macrophages and then undergo intracellular replication (Maphasa et al., 2021). In an attempt to conceal contaminated macrophages with fibrous tissue, the body forms granulomas and tubercles. Granulomas are often spherical, hard, yellow, or gray, and have a diameter of 1–3 cm. Dried cellular debris that is yellow, caseous, or necrotic makes up the granuloma’s core in one portion (Carrisoza-Urbina et al., 2019). The infection can cause smaller tubercles, measuring 2–3 mm in diameter, and spread hematogenously to the lymph nodes and other parts of the body. The term “miliary tuberculosis” refers to the development of these tiny tubercles (Sharma et al., 2016).
Clinical symptoms
Cattle that contract bovine tuberculosis might suffer from a persistent, crippling illness. In the early stages of the disease, there are no symptoms. But in the later stages, there is weakness, a low-grade temperature that fluctuates, gradual emaciation, and decreased appetite (Ramos et al., 2015). Shortness of breath, wet cough, or trachypnea may occur if there is an infection in the lungs. The location of lesions, which are primarily observed in the upper respiratory tract, lungs, and tonsils in both affected humans and animals, demonstrates the involvement of the respiratory tract and its function in the pathogenesis of the disease (Pal et al., 2022). A good appetite is frequently seen in cows with progressive emaciation that is unrelated to other clinical indicators, even if some of them have severe miliary tuberculosis lesions and are clinically normal (Krajewska-Wędzina et al., 2022). Temperature swings and erratic appetite are typically linked to this illness. The fur on the exterior could becoming abrasive.
Though their eyes stay bright and attentive, affected animals tend to become more submissive and lethargic (Ayele et al., 2004). These broad indicators frequently become more noticeable following the cow’s delivery. The hallmark of lung involvement is a persistent cough brought on by bronchopneumonia. The cough only happens once or twice at a time, is moist, and not very uncomfortable; it is more frequently triggered in the morning and during chilly weather (Bhatt et al., 2012). It is important to rule out bovine tuberculosis when there is a persistent loss of appetite and health, reduced milk production, and a crippling illness with or without respiratory symptoms.
In more severe situations, swollen lymph nodes may impede the digestive system, blood vessels, or airways. Head and neck lymph nodes may seem affected and occasionally rupture, releasing fluid (Skuce et al., 2012). Occasionally occurring diarrhea and constipation are signs of gastrointestinal tract involvement (Malikowski et al., 2018). Bloating may be brought on by pressure on the esophageal mediastinal glands, which are swollen. Dysphagia results from enlargement of the retropharyngeal glands (Rana et al., 2013). In the latter stages of tuberculosis, extreme emaciation and acute respiratory distress are possible. Male genitalia are rarely afflicted by lesions, although female genitalia can experience them occasionally (Borham et al., 2022). The significance of tuberculous mastitis stems from its potential harm to public health, its ability to spread to the clavicle, and the challenge of distinguishing it from other types of mastitis (Farrokh et al., 2019).
Descriptive statistics and regression models are used in data analysis to demonstrate that the majority of tuberculosis lesions are found in the respiratory system’s lymph nodes and lungs (Tulu et al., 2021). Typically, the disease has a protracted course and takes months or years to manifest symptoms. Clinical indicators that are frequently observed include anorexia, big, conspicuous lymph nodes, diarrhea, udder induration, recurring cough, weakness, loss of appetite, weight loss, and fluctuating temperature (Islam et al., 2021). Although it is mostly a crippling chronic illness, it can occasionally be acute and advance quickly (Menin et al., 2013).
The majority of infected livestock may be detected early because symptoms of infection are uncommon in nations with disease eradication initiatives (Good and Duignan, 2011). In the latter stages, gradual emaciation with fever, weakness, and irregular appetite are typical signs (Ramos et al., 2015). When exercising in cold weather in the morning, animals suffering from pulmonary disease typically have a more severe cough and may even get tachypnea or dyspnea (Sichewo et al., 2020). In their later stages, animals may experience respiratory problems and severe malnutrition. Animals become disoriented, unable to climb, and observed roaming around during the day in the later stages of the disease (Tschopp et al., 2009).
Human tuberculosis, which is caused by M. bovis, is typically a persistent and crippling illness. In the early stages of the disease, there are no symptoms (Torres-Gonzalez et al., 2016). Nevertheless, gradual emaciation, low-grade fever that fluctuates, weakness, a decrease in appetite, and nocturnal sweats characterize the last stages (Allen et al., 2021). Dyspnea, chest pain, wet cough, and tachypnea can all be symptoms of lung infection. Changes in temperature and changes in appetite are typically linked to this illness (Good et al., 2018).
Diagnosis
Clinical diagnosis
Clinical signs are used to make a provisional diagnosis of bovine tuberculosis. Cattle with bovine tuberculosis typically take months to show clinical symptoms. Additionally, infections can lie latent for years before resurfacing in old age or during stressful situations. Clinical indicators of an M. bovis infection include low-grade fever, persistent weakness, wet cough, and swollen local lymph nodes (Lema and Dame, 2022).
Post mortem diagnosis
To detect tubercles, the lymph nodes, particularly those connected to the head, chest, and belly, are closely inspected during the postmortem examination (Ramos et al., 2015). The progressively developing tubercles, known as granulomas, in every bodily tissue and organ are indicative of severe pathological alterations in the carcass. These granulomas typically have a yellowish hue, are caseous or calcified, and are frequently encapsulated (Carrisoza-Urbina et al., 2019). Certain species, like deer, have lesions that more closely resemble abscesses than ordinary tubercles (Gormley and Corner, 2018). Certain tubercles are so tiny that they must be sliced open to be seen with the naked eye. Tubercles in cattle are typically seen in the lymph nodes on the head and chest. This typically affects the surface of bodily cavities, the lungs, the spleen, and the liver (Palmer et al., 2022).
Tuberculin skin test (TST)
The TST involves injecting M. bovis pure protein derivative (PPD) tuberculin subcutaneously, followed three days later by looking for swelling (delayed hypersensitivity) at the injection site (Coad et al., 2010). For many years, the TST has been an effective epidemiological and diagnostic tool for managing tuberculosis in cows (Carneiro et al., 2021). The injection is referred to as tuberculin. The protein solution found in the cell walls of mycobacterium species is utilized to produce tuberculin (Maitra et al., 2019). The injection of this protein solution into the skin of an infected animal triggers a local inflammatory reaction by the body’s sensitized immune system, which results in the telltale signals of a positive tuberculin test (Encinales et al., 2010). There would not be an inflammatory response in animals who have not been exposed to bovine tuberculosis.
IFNɣ assay test
This test is usually carried out in the laboratory by using freshly collected blood samples. It involves measuring the level of a type of ctytokine (an immunological messenger protein) which is called “interferon gamma (IFNɣ)”. The white blood cells of cattle release IFNɣ when they are infected with tuberculosis after stimulation with bovine and avian tuberculins. Blood samples from cattle infected with bovine tuberculosis can be used to measure the IFNɣ level (Ghielmetti et al., 2021).
Bacterial isolation
Mycobacteria can be isolated using Lowenstein-Jensen media, while M. bovis can be isolated by cultivating on media (Claro-Almea et al., 2020). Eugenics is the term used to describe the profuse development of M. tuberculosis on glycerol-containing media, which gives the colony characteristics of being glossy, hard, and rough (Keating et al., 2005). Eugenics is another term for the growth of M. avium on glycerol-containing media (Mayahi et al., 2013). Mycobacterium bovis grows poorly in medium containing glycerol, a condition known as dysgenic growth, but grows effectively on media containing pyruvate in the absence of glycerol (Claro-Almea et al., 2020). The international gold standard for determining mycobacterial infection is still bacterial culture. However, it is difficult and time-consuming to identify M. bovis using culture and biochemical approaches because of its dysgenic features and slow growth (Yatbantoong and Rukkwamsuk, 2017). Furthermore, the utilization of molecular techniques is costly due to the need for sufficient laboratory resources and skilled personnel.
Molecular diagnostics
The typical test protocol for M. bovis can be laborious, slow, complex, inaccurate, non-reproducible, and time-consuming. It can also produce ambiguous results and be executed outside of a laboratory. However, direct detection of M. bovis in clinical samples is also possible using molecular methods like PCR (Mishra et al., 2005). PCR is very helpful for the direct detection of M. bovis in samples of bovine tissue and has been effectively used to identify members of the M. tuberculosis complex (Santos et al., 2020). Other studies have indicated the usefulness of multiplex-PCR as a complementation tool in differentiating M. bovis from other cultured M. tuberculosis Complex (MTC) species as they applied a multiplex-PCR to differentiate M. bovis from MTC by one-step amplification based on simultaneous detection of pncA 169C > G change in M. bovis and the IS6110 present in MTC species (Spositto et al., 2014). Additionally, distinct M. bovis strains can be distinguished from one another using genetic fingerprinting methods like spoligotyping. A molecular epidemiological surveillance study of 940 positive mycobacteria growth indicator tube (MGIT) cultures that were collected from patients with suspected tuberculosis visiting an outpatient department in a hospital in India using a PCR-based and whole-genome sequencing (WGS) approach indicated that isolates consisted of M tuberculosis [913 (97·1%) isolates], Mycobacterium orygis [seven (0·7%)], M bovis bacillus calmette-guerin (BCG) [five (0·5%)], and non-tuberculous mycobacteria [15 (1·6%)]. Subspecies were assigned for 25 isolates by WGS, which were analyzed against 715 MTBC sequences from south Asia. Among the 715 genomes, no M bovis was identified. Four isolates of cattle origin were also dispersed among human sequences within M tuberculosis lineage 1, and the seven M orygis isolates from human MGIT cultures were dispersed among sequences from cattle (Duffy et al., 2020). This study showed that M bovis prevalence in humans is an inadequate proxy of zoonotic tuberculosis. Additionally, the recovery of M orygis from humans highlights the need to use a broadened definition, including MTBC subspecies such as M orygis, to investigate zoonotic tuberculosis. The identification of M tuberculosis in cattle also reinforces the need for One Health investigations in countries with endemic bovine tuberculosis (Duffy et al., 2020).
Enzyme-linked immunosorbent assay (ELISA)
Tests such as ELISA (B cell-mediated immunity) is one of the options for detecting antibodies. The degree to which certain antibodies bind to antigens is not directly measured by the ELISA technique (Waritani et al., 2017). The purified antigens of M. bovis, such as the Ag85 antigen, which comprises the majority of secreted proteins, MPB70 and MPB83 protein, which are highly homologous mycobacterial proteins with restricted distribution, are the antigens typically utilized to diagnose livestock infected with M. bovis (Wiker, 2009). The benefit of ELISA is its ease of use; nevertheless, its sensitivity is primarily reduced because to the weak and non-teraturing humoral response in the sap throughout illness progression (Sakamoto et al., 2018). ELISA may be easily automated to process a large number of samples at a comparatively low cost.
Transmission
The majority of data on zoonotic mycobacterial transmission originates from studies conducted on M. bovis. These germs can be found in respiratory secretions, milk, vaginal secretions, semen, urine, feces, and exudates from lesions (such as lymph node drainage and some skin lesions), depending on the location (Bolaños et al., 2017). The degree of infection varies between species and can happen multiple times. When the respiratory system is impacted and the disease progresses to later stages with more extensive lesions, there is an increased risk of Mycobacterium bovis transmission (Phillips et al., 2003). This bacteria spreads more easily when people are in close quarters. Additionally, the illness has been cultured from the oral secretions of certain animals, such as ferrets, which may make bites a more effective means of transmission (Palmer et al., 2012).
Animals can also contract an infection by direct contact with infected skin wounds or mucous membranes, ingestion, or inhalation (Phipps et al., 2018). When causing an infection by swallowing, a far higher concentration of bacteria is typically required than when inhaling them (Ayalew et al., 2023). The significance of different transmission pathways differs depending on the host species. Aerosols from close contact can frequently infect cattle. In this species, ingestion-based transmission is uncommon, with the exception of breastfeeding calves of infected cows (Herrera-Rodríguez et al., 2013). Although it seems uncommon, dermal, genital (sexual), and congenital transmission are all possible in cattle (Skuce et al., 2012). Most of the time, these germs are most likely spread by aerosol; however, one cow event may have been caused by hay tainted with urine (Good and Duignan, 2011).
In a number of other animals, including camels, monkeys, and civets, inhalation transmission is also believed to predominate (Mohamed, 2020). However, it is believed that ingestion occurs most frequently in deer, horses, cats, and ferrets (Broughan et al., 2013). Particularly in hunting or combative species like cats and ferrets, percutaneous transmission is observed (De Garine-Wichatitsky et al., 2013). When cats wash their mucous membranes after feeding, they may also introduce bacteria into those membranes (O’Halloran et al., 2019). It is believed that dogs with kidney lesions can spread M. bovis through their urine in kennels (Allen et al., 2021). There have been reports of nosocomial transmission at veterinary clinics. In one instance, probably by hand or clothing, bacteria from an ill cat were transferred to a healthy feline patient undergoing surgery (O’Connor et al., 2019). Additionally, raw meat consumption has been associated with bTB transmission, especially among carnivorous domesticated, wild, and captive animals when they consume infected raw meat (Deneke et al., 2022).
Similar to animals, humans can contract an infection through eating, inhalation, or direct contact with wounds on their skin or mucous membranes (Phipps et al., 2019). Oral infection is a common form of exposure when consuming unpasteurized dairy products (Collins and More, 2022). Additionally, raw or undercooked meat and other animal tissues contain M. bovis (Clausi et al., 2021). Human cases are rarely linked to animal bites. It is possible for an infection to spread from person to person, particularly through the respiratory system (Sichewo et al., 2020). At least one investigation raises the possibility of M. bovis respiratory transmission through casual community contact, although these occurrences typically involve intimate contacts, such as family (Torres-Gonzalez et al., 2016). There is also a chance that M. microti can spread from person to person (Emmanuel et al., 2007). There are records of human-to-animal transmissions of M. bovis and M. orygis (Baker et al., 2006; Sumanth et al., 2023).
The factors that impact the environmental survival of M. bovis and its closely related species are temperature, humidity, sunlight exposure, temperature and humidity changes, competition with other microorganisms, and initial bacterial load (Barbier et al., 2017). Particularly in cold, dark, and moist environments, M. bovis can live for several months in soil and other materials (such as food and excrement) (Fine et al., 2011). However, the illness goes away in a matter of days or weeks, particularly in situations where it is exposed to dry conditions, high temperatures, and intense sunshine (Broughan et al., 2016). It has been documented that M. bovis can survive for up to a year in ideal laboratory settings when grown in dung or soil (Robinson, 2019). The quantity of viable M. bovis considerably dropped within the first two weeks of one investigation, which investigated soil, water, straw, and shelled maize stored outside in open containers (Fine et al., 2011). However, a tiny number of bacteria survived longer. Mycobacterium bovis is rarely isolated from soil or pastures grazed by infected livestock, but it is unclear whether this is due to the inactivation of the microorganism or difficulty in isolating it from locations with competing bacteria that grow more easily in cultivation.
Risk factor
In humans
Human populations living in poverty, poor socioeconomic groups, low income, low immunity (including AIDS), extreme age groups (old age and children), specific ethnic groups, migrants, and contacts with animals exposed to M. bovis are all thought to have a significant risk of contracting bovine tuberculosis (Toribio et al., 2023). In some societies around the world, the consumption of raw meat and unpasteurized milk is a deeply-rooted cultural habit. In fact, some people have the opinion that the pasteurizing and boiling process destroys the milk. Additionally, in some countries, such as Ethiopia, eating raw meat or half cooked meat such as poultry, beef, mutton, goat, and fish is very common and culturally acceptable while eating other types of meat such as pork is a cultural taboo while camel meat is acceptable in the Muslim community (Deneke et al., 2022). In such countries where pasteurization and poor milk and meat hygiene are not properly and widely practiced, about 10%–15 % of all human TB cases are likely caused by M. bovis (Deneke et al., 2022). The likelihood of spreading M. bovis also rises with proximity to and length of interaction with M. bovis carriers (Devi et al., 2021).
In animals
Cattle breed, physiological state, age, genetic resistance, sex, concurrent infections, stress, immune status, and body condition score are examples of animal-level risk factors (Kazwala et al., 2001). Numerous research studies have demonstrated that different breeds of cattle may differ in their susceptibility to bovine tuberculosis; one such study indicates that native zebu cattle are more resistant to the disease than foreign varieties (Vordermeier et al., 2012). Genetically modified animals may experience more severe hunger and housing shortages, making them more prone to illness (Mohamed, 2020). The age of the animal is one of the primary risk factors for animals that have been found by numerous research in both developed and developing nations. Age increases the length of exposure (Humblet et al., 2009).
Young animals may contract the infection, but symptoms don’t manifest until they are adults (O’Brien et al., 2023). Mycobacteria can lie dormant in elderly animals for extended periods of time before reactivating. Animals often exhibit a reduced reaction to the tuberculin test as they get older (over 5 years old), as the immunological response likewise diminishes (Byrne et al., 2022). Management procedures or behavioral patterns may be influenced by gender-related variables. During breeding, male animals may interact with other herds more frequently, which raises the possibility of illness (Mekonnen et al., 2019). Insufficient feed or an inadequate diet resulting from insufficient protein, minerals, and vitamins might weaken an animal’s fight against bovine tuberculosis (Carwile et al., 2022).
The quantity of herds, the types of livestock practices and cattle housing, animal-wildlife contact, the introduction of new cattle into the farm, herd movement and trade, and the history of bovine tuberculosis in animal groups and humans who have contracted the disease from M. bovis in the home are all examples of risk factors for the spread of bovine tuberculosis (Dejene et al., 2016). Under nomadic circumstances, herd contact and an increase in the overall size of the herd both greatly raise the risk of exposure to M. bovis (Skuce et al., 2012). Potential risk factors include the disease prevalence rate in the territory or reservoir host of the domestic animal, the size of the herd (density) of wildlife, and the history of M. bovis in wildlife populations in the past when there is direct wildlife interaction or sharing the environment with domestic livestock (Fitzgerald and Kaneene, 2013).
Public health importance
Since there is no clinical, radiographic, or histological distinction between tuberculosis caused by M. tuberculosis and M. bovis, tuberculosis in humans caused by M. bovis is typically underestimated or underdiagnosed. Although M. bovis is not the primary cause of tuberculosis in humans, humans can contract the disease by inhaling droplets, eating raw milk, meat, and other animal products, or by coming into direct contact with sick animals (Olea-Popelka et al., 2017). An estimated 10% of human tuberculosis cases are thought to be caused by M. bovis, with M. tuberculosis being the primary cause (Müller et al., 2013). Human tuberculosis cases caused by M. bovis will decrease in nations where pasteurized milk is utilized and where successful bovine tuberculosis programs are put in place (Davidson et al., 2017). However, disease reporting is more common in regions where cattle disease is poorly managed. The incidence rate is higher among those who work in slaughterhouses, breed livestock, and other related fields (Mia et al., 2022).
Human infections can result from exposure to non-cattle species. Goats, captive-bred deer, seals, and rhinoceroses have all been reported to be potential reservoirs of bovine tuberculosis (Cousins et al., 1993; Napp et al., 2013; Busch et al., 2017; Dwyer et al., 2020). Wild animals may be the source of the bacteria, particularly in nations where people frequently consume wild animal meat (De Garine-Wichatitsky et al., 2013). This demonstrates the high rate of tuberculosis transmission in the community, indicating the need for urgent attention from the perspectives of public health and the economy. The presence of tubercle bacilli raises the risk of lung and bladder cancer, and this condition produces chronic granulomatous disease (Fol et al., 2021). Bladder cytotoxicity caused by BCG cleared the path for the introduction of BCG immunotherapy as a bladder cancer treatment (Guallar-Garrido and Julián, 2020).
Economic impact
Accurately estimating the financial impact of bovine tuberculosis on animal output is extremely challenging. This illness generally lowers cattle productivity and could have a negative financial impact on the livestock business, particularly the dairy industry (Tschopp et al., 2021). The effect of infection risk on people is especially significant, since women and children seem to be more susceptible to the illness in nations with low socioeconomic status and inadequate veterinary and public health care (Agbalaya et al., 2020). All available data show that there are significant global economic losses due to bovine tuberculosis, even though estimates of the expenses connected with the disease and its control only apply to certain nations (Pérez-Morote et al., 2020). These losses cover costs associated with putting monitoring and control measures into place as well as losses from animal production, markets, and trading (Tschopp et al., 2021). The losses resulting from bovine tuberculosis are especially noteworthy when they include endangered wildlife species.
In general, there are distinct effects of bovine tuberculosis on the domestic and global economies. The most noticeable effect of bovine tuberculosis in cattle is a direct reduction in productivity, which is divided into losses from livestock and losses from slaughter (Pérez-Morote et al., 2020). The expenses incurred for condemnation and livestock retention make up the losses resulting from slaughter; the former represents the animal’s purchase price, while the latter represents a minor fraction of the carcass value (Kapalamula et al., 2013). Livestock losses include lower production of milk and meat, more reproductive effort, and the expense of replacing sick animals (Borja et al., 2018).
Bovine tuberculosis not only directly reduces production but also has significant negative economic effects on both domestic and international trade. Due to the restriction on importing animals and animal products from nations where the illness is enzootic, bovine tuberculosis has an impact on access to international markets (Humblet et al., 2009). Major repercussions of this circumstance also extend to other livestock-related economic sectors. Furthermore, bovine tuberculosis can lead to inefficiencies in global markets. For instance, nations that export animal goods but are economically inefficient and disease-free will earn more money than economically efficient countries who are unable to export such items because of enzootic bovine tuberculosis (Gong et al., 2021). There are significant economic ramifications when this disease is found in wildlife (De Garine-Wichatitsky et al., 2013). In addition to being more expensive and difficult to eradicate, bovine tuberculosis has the potential to disrupt entire ecosystems, with unpredictably negative effects on a variety of private domains, including tourism and agricultural land (Kemal et al., 2019).
Treatment
In particular, farm, pet, and zoo animals have been treated with antibiotics for bovine tuberculosis (Robinson, 2019). However, one should be aware that clinical improvement might occur even in the absence of a bacteriological cure. Even some initially responsive animals eventually relapse, particularly when treatment is insufficient (e.g., a single medicine is used or the length of treatment is too short) (Borham et al., 2022). Treatment is controversial due to the possibility of medication resistance developing, the risk of germs spreading, and the potential harm to people, particularly if there are drainage lesions or an infection of the respiratory system (Palmer and Waters, 2011).
Many popular antibiotics do not affect M. bovis complex members. Treatment for this illness is restricted to small doses of tuberculocidal medications (Chuang et al., 2020). Animal treatment typically follows human-successfully implemented techniques, with two or more medications administered concurrently over several months (Meiring et al., 2018). It should be kept in mind while choosing antibiotics that M. bovis is innately resistant to pyrazinamide, with very few exceptions (de Jong et al., 2005). The most effective first-line anti-tuberculosis chemotherapy consists of isoniazid, ethambutol, rifampin, and streptomycin (du Toit et al., 2006). Second-line drugs used against bovine tuberculosis include ethionamide, capreomycin, thioacetazone, and cycloserine (Sandhu, 2011).
In regions with official control programs, vaccination against bovine tuberculosis is rarely used to control the disease because BCG can trigger a cellular immune response, which can interfere with testing methods that use PPD as the antigen (TST and interferon gamma release assay) (Balseiro et al., 2020). A significant challenge is the absence of diagnostic techniques to distinguish between animals that are vaccinated and those that are infected. Furthermore, there are a number of difficulties with the live attenuated BCG vaccine, including its stability in unpredictable environmental circumstances and its potential for survival in bodily tissues, secretions, and the environment (Angelidou et al., 2020). Nonetheless, current research using BCG in cattle indicates that giving this medication to newborns is highly successful (Hope et al., 2005).
Control
The prevention and control of bovine tuberculosis is necessary because sick animals lose productivity and humans are at risk of contracting the disease. However, control efforts are not implemented or are not implemented well enough in the majority of developed countries due to financial constraints, a lack of skilled professionals, a lack of political will, and a low assessment of the importance of zoonotic bovine tuberculosis in the animal and public health sectors by national governments and donor agencies (Ramanujam and Palaniyandi, 2023). To prevent person-to-person transmission, patients infected with M. bovis should be treated with the same public health procedures used to treat patients with infectious M. tuberculosis (Silva et al., 2013). Cattle with tuberculosis should not receive any treatment at all, and any affected livestock should be slaughtered. This is because M. bovis is resistant to pyrazinamide, a medication that is frequently used to treat infections in people brought on by M. tuberculosis complex (de Jong et al., 2005).
To successfully control and eradicate bovine tuberculosis, developed nations have implemented routine testing and culling of infected animals under national mandatory programs. Interestingly, many industrialized countries have reached officially tuberculosis-free status. However, infection of cattle with M. bovis still occurs in most countries around the world, especially in low- and middle-income countries because bTB control programs are often not implemented. This non-implementation is mostly because standard TB control through testing and culling, movement control, and slaughterhouse inspection is too expensive or ethically unacceptable, sometimes due to religious reasons (Gortázar et al., 2023). Additionally, some countries lack sufficient knowledge on the MTB complex maintenance community which draws back improvements in TB control by targeting the whole host community (Gortázar et al., 2023). For a successful bTB control, evidence of close interactions among all forms of possible hosts needs to be addressed synchronously.
Between 1953 and 1980, this program was successful in many European Union member states as well as seven countries in central Europe (Jemal, 2016). It is necessary to provide specific hygiene standards for foods of animal origin to stop diseased animals from getting into the food chain and lower the hazards connected with consuming tainted milk and meat (Tora et al., 2022). Systems for inspecting meat need to be improved and intended to stop the general population from consuming tainted goods. An examination must be performed both pre- and post-mortem on any animal that enters the food chain (Clausi et al., 2021).
The tuberculin test is the primary method for detecting bovine tuberculosis in cows (Coad et al., 2010). Standard bovine tuberculosis control techniques include testing and slaughterhouse inspection (Ramos et al., 2022). This disease will be lessened with the use of meat screening in slaughterhouses and the identification of the animals’ herd origin (Abbate et al., 2020). The early detection of preclinical infection in animals meant for food production and the prompt removal of diseased animals from the herd will prevent future sources of infection for people and other animals, making tuberculin testing helpful in the control of bovine tuberculosis (Good and Duignan, 2011). A tuberculin test needs to be done on cattle 12 months before slaughter. Collaboration between veterinary and medical specialists is crucial in the event of a disease outbreak.
Conclusion
Bovine tuberculosis is a global disease that affects the cattle-producing industry greatly economically. However, the requirement for pasteurization of milk, tuberculin testing of cow skin, and culling of diseased cattle has resulted in a dramatic drop in the incidence of human tuberculosis caused by M. bovis in developed countries. The prevention and control of bovine tuberculosis is necessary because sick animals lose productivity and humans are at risk of contracting the disease.
Acknowledgments
The authors thank the Universitas Airlangga and Badan Riset dan Inovasi Nasional.
Author’s contributions
ARK, IBM, YP, and MKJK drafted the manuscript. SRA, WT, and FAR revise and edits the manuscripts. OSMS, IF, and SA took part in preparing and critical checking this manuscript. AH, SMY, HMR, and NN edits the references. All authors read and approved the final manuscript.
Conflict of interest
The authors declare that there is no conflict of interest.
Funding
This study was supported by the Badan Riset dan Inovasi Nasional, Indonesia, who provided funding for this study by Penerima Program Riset dan Inovasi Untuk Indonesia Maju, year 2023, with grant number: 37/II.7/HK/2023.
Data availability
All references are open access, so data can be obtained from the online web.
References
- Abbate J.M, Arfuso F, Iaria C, Arestia G, Lanteri G. Prevalence of bovine tuberculosis in slaughtered cattle in sicily, Southern Italy. Animals (Basel) 2020;10(9):1473. doi: 10.3390/ani10091473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Agbalaya M.A, Ishola O.O, Adesokan H.K, Fawole O.I. Prevalence of bovine tuberculosis in slaughtered cattle and factors associated with risk of disease transmission among cattle handlers at Oko-Oba Abattoir, Lagos, Nigeria. Vet. World. 2020;13(8):1725–1731. doi: 10.14202/vetworld.2020.1725-1731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Allen A.R, Ford T, Skuce R.A. Does Mycobacterium tuberculosis var. bovis survival in the environment confound bovine tuberculosis control and eradication? a literature review. Vet. Med. Int. 2021;2021(1):8812898. doi: 10.1155/2021/8812898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Allen A.R, Skuce R.A, Byrne A.W. Bovine tuberculosis in britain and Ireland - a perfect storm? the confluence of potential ecological and epidemiological impediments to controlling a chronic infectious disease. Front. Vet. Sci. 2018;5(1):109. doi: 10.3389/fvets.2018.00109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Andersen C.S, Agger E.M, Rosenkrands I, Gomes J.M, Bhowruth V, Gibson K.J, Petersen R.V, Minnikin D.E, Besra G.S, Andersen P. A simple mycobacterial monomycolated glycerol lipid has potent immunostimulatory activity. J. Immunol. 2009;182(1):424–432. doi: 10.4049/jimmunol.182.1.424. [DOI] [PubMed] [Google Scholar]
- Angelidou A, Diray-Arce J, Conti M.G, Smolen K.K, van Haren S.D, Dowling D.J, Husson R.N, Levy O. BCG as a case study for precision vaccine development: lessons from vaccine heterogeneity, trained immunity, and immune ontogeny. Front. Microbiol. 2020;11(1):332. doi: 10.3389/fmicb.2020.00332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Avila L.N, Gonçalves V.S.P, Perez A.M. Risk of introduction of bovine tuberculosis (TB) into TB-free herds in Southern Bahia, Brazil, Associated with movement of live cattle. Front. Vet. Sci. 2018;5(1):230. doi: 10.3389/fvets.2018.00230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ayalew S, Habtamu G, Melese F, Tessema B, Ashford R.T, Chothe S.K, Aseffa A, Wood J.L.N, Berg S, Mihret A. Zoonotic tuberculosis in a high bovine tuberculosis burden area of Ethiopia. Front. Public Health. 2023;11(1):1204525. doi: 10.3389/fpubh.2023.1204525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ayele W.Y, Neill S.D, Zinsstag J, Weiss M.G, Pavlik I. Bovine tuberculosis: an old disease but a new threat to Africa. Int. J. Tuberc. Lung Dis. 2004;8(8):924–937. [PubMed] [Google Scholar]
- Baker M.G, Lopez L.D, Cannon M.C, De Lisle G.W, Collins D.M. Continuing Mycobacterium bovis transmission from animals to humans in New Zealand. Epidemiol. Infect. 2006;134(5):1068–1073. doi: 10.1017/S0950268806005930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Balseiro A, Thomas J, Gortázar C, Risalde M.A. Development and challenges in animal tuberculosis vaccination. Pathogens. 2020;9(6):472. doi: 10.3390/pathogens9060472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barbier E, Rochelet M, Gal L, Boschiroli M.L, Hartmann A. Impact of temperature and soil type on Mycobacterium bovis survival in the environment. PLoS One. 2017;12(4):e0176315. doi: 10.1371/journal.pone.0176315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bhatt M, Kant S, Bhaskar R. Pulmonary tuberculosis as differential diagnosis of lung cancer. South Asian J. Cancer. 2012;1(1):36–42. doi: 10.4103/2278-330X.96507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bihon A, Zinabu S, Muktar Y, Assefa A. Human and bovine tuberculosis knowledge, attitude and practice (KAP) among cattle owners in Ethiopia. Heliyon. 2021;7(3):e06325. doi: 10.1016/j.heliyon.2021.e06325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bolaños C.A.D, Paula C.L, Guerra S.T, Franco M.M.J, Ribeiro M.G. Diagnosis of mycobacteria in bovine milk: an overview. Rev. Inst. Med. Trop. Sao Paulo. 2017;59(1):e40. doi: 10.1590/S1678-9946201759040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borham M, Oreiby A, El-Gedawy A, Hegazy Y, Khalifa H.O, Al-Gaabary M, Matsumoto T. Review on bovine tuberculosis: an emerging disease associated with multidrug-resistant Mycobacterium species. Pathogens. 2022;11(7):715. doi: 10.3390/pathogens11070715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borja E, Borja L.F, Prasad R, Tunabuna T, Toribio J.L.M.L. A retrospective study on bovine tuberculosis in cattle on Fiji: study findings and stakeholder responses. Front. Vet. Sci. 2018;5(1):270. doi: 10.3389/fvets.2018.00270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bouchez-Zacria M, Courcoul A, Durand B. The distribution of bovine tuberculosis in cattle farms is linked to cattle trade and badger-mediated contact networks in South-Western France, 2007-2015. Front. Vet. Sci. 2018;5(1):173. doi: 10.3389/fvets.2018.00173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Broughan J.M, Downs S.H, Crawshaw T.R, Upton P.A, Brewer J, Clifton-Hadley R.S. Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 1: review of epidemiology and laboratory submissions in Great Britain 2004-2010. Vet. J. 2013;198(2):339–345. doi: 10.1016/j.tvjl.2013.09.006. [DOI] [PubMed] [Google Scholar]
- Broughan J.M, Judge J, Ely E, Delahay R.J, Wilson G, Clifton-Hadley R.S, Goodchild A.V, Bishop H, Parry J.E, Downs S.H. A review of risk factors for bovine tuberculosis infection in cattle in the UK and Ireland. Epidemiol. Infect. 2016;144(14):2899–2926. doi: 10.1017/S095026881600131X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Busch F, Bannerman F, Liggett S, Griffin F, Clarke J, Lyashchenko K.P, Rhodes S. Control of bovine tuberculosis in a farmed red deer herd in England. Vet. Rec. 2017;180(3):68. doi: 10.1136/vr.103930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Byrne A.W, Barrett D, Breslin P, Fanning J, Casey M, Madden J.M, Lesellier S, Gormley E. Bovine tuberculosis in youngstock cattle: a narrative review. Front. Vet. Sci. 2022;9(1):1000124. doi: 10.3389/fvets.2022.1000124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cambau E, Drancourt M. Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882. Clin. Microbiol. Infect. 2014;20(3):196–201. doi: 10.1111/1469-0691.12555. [DOI] [PubMed] [Google Scholar]
- Carneiro P.A.M, Sousa E.M, Viana R.B, Monteiro B.M, Kzam A.S.L, de Souza D.C, Coelho A.S, Filho J.D.R, Jordao R.S, Tavares M.R.M, Kaneene J.B. Study on supplemental test to improve the detection of bovine tuberculosis in individual animals and herds. BMC Vet. Res. 2021;17(1):137. doi: 10.1186/s12917-021-02839-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carrisoza-Urbina J, Morales-Salinas E, Bedolla-Alva M.A, Hernández-Pando R, Gutiérrez-Pabello J.A. Atypical granuloma formation in Mycobacterium bovis-infected calves. PLoS One. 2019;14(7):e0218547. doi: 10.1371/journal.pone.0218547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carwile M.E, Hochberg N.S, Sinha P. Undernutrition is feeding the tuberculosis pandemic: a perspective. J. Clin. Tuberc. Other Mycobact. Dis. 2022;27(1):100311. doi: 10.1016/j.jctube.2022.100311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chuang Y.M, Dutta N.K, Gordy J.T, Campodónico V.L, Pinn M.L, Markham R.B, Hung C.F, Karakousis P.C. Antibiotic treatment shapes the antigenic environment during chronic TB infection, offering novel targets for therapeutic vaccination. Front. Immunol. 2020;11(1):680. doi: 10.3389/fimmu.2020.00680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Claro-Almea F.E, Delgado-Noguera L.A, Motaban A, España M, de Waard J.H. A rare case of spinal tuberculosis due to Mycobacterium bovis. Is zoonotic tuberculosis underdiagnosed? IDCases. 2020;22(1):e00982. doi: 10.1016/j.idcr.2020.e00982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clausi M.T, Ciambrone L, Zanoni M, Costanzo N, Pacciarini M, Casalinuovo F. Evaluation of the presence and viability of Mycobacterium bovis in Wild Boar meat and meat-based preparations. Foods. 2021;10(10):2410. doi: 10.3390/foods10102410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coad M, Clifford D, Rhodes S.G, Hewinson R.G, Vordermeier H.M, Whelan A.O. Repeat tuberculin skin testing leads to desensitisation in naturally infected tuberculous cattle which is associated with elevated interleukin-10 and decreased interleukin-1 beta responses. Vet. Res. 2010;41(2):14. doi: 10.1051/vetres/2009062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collins A.B, More S.J. Parameter estimates to support future risk assessment of Mycobacterium bovis in raw milk cheese. Microb. Risk Anal. 2022;21(1):100204. [Google Scholar]
- Cousins D.V, Williams S.N, Reuter R, Forshaw D, Chadwick B, Coughran D, Collins P, Gales N. Tuberculosis in wild seals and characterisation of the seal bacillus. Aust. Vet. J. 1993;70(3):92–97. doi: 10.1111/j.1751-0813.1993.tb03284.x. [DOI] [PubMed] [Google Scholar]
- Datta M, Via L.E, Chen W, Baish J.W, Xu L, Barry C.E, Jain R.K. Mathematical model of oxygen transport in tuberculosis granulomas. Ann. Biomed. Eng. 2016;44(4):863–872. doi: 10.1007/s10439-015-1415-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davidson J.A, Loutet M.G, O’Connor C, Kearns C, Smith R.M, Lalor M.K, Thomas H.L, Abubakar I, Zenner D. Epidemiology of Mycobacterium bovis disease in humans in England, Wales, and Northern Ireland, 2002-2014. Emerg. Infect. Dis. 2017;23(3):377–386. doi: 10.3201/eid2303.161408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Garine-Wichatitsky M, Caron A, Kock R, Tschopp R, Munyeme M, Hofmeyr M, Michel A. A review of bovine tuberculosis at the wildlife-livestock-human interface in sub-Saharan Africa. Epidemiol. Infect. 2013;141(7):1342–1356. doi: 10.1017/S0950268813000708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Jong B.C, Onipede A, Pym A.S, Gagneux S, Aga R.S, DeRiemer K, Small P.M. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis? J. Clin. Microbiol. 2005;43(7):3530–3532. doi: 10.1128/JCM.43.7.3530-3532.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dejene S.W, Heitkönig I.M, Prins H.H, Lemma F.A, Mekonnen D.A, Alemu Z.E, Kelkay T.Z, de Boer W.F. Risk factors for bovine tuberculosis (bTB) in cattle in Ethiopia. PLoS One. 2016;11(7):e0159083. doi: 10.1371/journal.pone.0159083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Deneke T.T, Bekele A, Moore H.L, Mamo T, Almaw G, Mekonnen G.A, Mihret A, Tschopp R, Yeheyis L, Hodge C, Wood J.L.N, Berg S ETHICOBOTS consortium. Milk and meat consumption patterns and the potential risk of zoonotic disease transmission among urban and peri-urban dairy farmers in Ethiopia. BMC Public Health. 2022;22(1):222. doi: 10.1186/s12889-022-12665-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Devi K.R, Lee L.J, Yan L.T, Syafinaz A.N, Rosnah I, Chin V.K. Occupational exposure and challenges in tackling M. bovis at human-animal interface: a narrative review. Int. Arch. Occup. Environ. Health. 2021;94(6):1147–1171. doi: 10.1007/s00420-021-01677-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dhama K, Mahendran M, Tiwari R, Singh S.D, Kumar D, Singh S, Sawant P.M. Tuberculosis in birds: insights into the Mycobacterium avium infections. Vet. Med. Int. 2011;2011(1):712369. doi: 10.4061/2011/712369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- du Toit L.C, Pillay V, Danckwerts M.P. Tuberculosis chemotherapy: current drug delivery approaches. Respir. Res. 2006;7(1):118. doi: 10.1186/1465-9921-7-118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duffy S.C, Srinivasan S, Schilling M.A, Stuber T, Danchuk S.N, Michael J.S, Venkatesan M, Bansal N, Maan S, Jindal N, Chaudhary D, Dandapat P, Katani R, Chothe S, Veerasami M, Robbe-Austerman S, Juleff N, Kapur V, Behr M.A. Reconsidering Mycobacterium bovis as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance study. Lancet Microbe. 2020;1(2):e66–e73. doi: 10.1016/S2666-5247(20)30038-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dwyer R.A, Witte C, Buss P, Goosen W.J, Miller M. Epidemiology of tuberculosis in multi-host wildlife systems: implications for black (Diceros bicornis) and White (Ceratotherium simum) Rhinoceros. Front. Vet. Sci. 2020;7(1):580476. doi: 10.3389/fvets.2020.580476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Emmanuel F.X, Seagar A.L, Doig C, Rayner A, Claxton P, Laurenson I. Human and animal infections with Mycobacterium microti, Scotland. Emerg. Infect. Dis. 2007;13(12):1924–1927. doi: 10.3201/eid1312.061536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Encinales L, Zuñiga J, Granados-Montiel J, Yunis M, Granados J, Almeciga I, Clavijo O, Awad C, Collazos V, Vargas-Rojas M.I, Bañales-Mendez J.L, Vazquez-Castañeda L, Stern J.N, Romero V, Fridkis-Hareli M, Terreros D, Fernandez-Viña M, Yunis E.J. Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis. Mol. Immunol. 2010;47(5):1066–1073. doi: 10.1016/j.molimm.2009.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farrokh D, Alamdaran A, Laeen A.F, Rastegar Y.F, Abbasi B. Tuberculous mastitis: a review of 32 cases. Int. J. Infect. Dis. 2019;87(1):135–142. doi: 10.1016/j.ijid.2019.08.013. [DOI] [PubMed] [Google Scholar]
- Fine A.E, Bolin C.A, Gardiner J.C, Kaneene J.B. A study of the persistence of Mycobacterium bovis in the environment under natural weather conditions in Michigan, USA. Vet. Med. Int. 2011;2011(1):765430. doi: 10.4061/2011/765430. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fitzgerald S.D, Kaneene J.B. Wildlife reservoirs of bovine tuberculosis worldwide: hosts, pathology, surveillance, and control. Vet. Pathol. 2013;50(3):488–499. doi: 10.1177/0300985812467472. [DOI] [PubMed] [Google Scholar]
- Fol M, Koziński P, Kulesza J, Białecki P, Druszczyńska M. Dual nature of relationship between Mycobacteria and cancer. Int. J. Mol. Sci. 2021;22(15):8332. doi: 10.3390/ijms22158332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallivan M, Shah N, Flood J. Epidemiology of human Mycobacterium bovis disease, California, USA 2003-2011. Emerg. Infect. Dis. 2015;21(3):435–443. doi: 10.3201/eid2103.141539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Getahun M, Blumberg H.M, Sinshaw W, Diriba G, Mollalign H, Tesfaye E, Yenew B, Taddess M, Zewdie A, Dagne K, Beyene D, Kempker R.R, Ameni G. Low prevalence of Mycobacterium bovis in tuberculosis patients, Ethiopia. Emerg. Infect. Dis. 2020;26(3):613–615. doi: 10.3201/eid2603.190473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghazaei C. Mycobacterium tuberculosis and lipids: insights into molecular mechanisms from persistence to virulence. J. Res. Med. Sci. 2018;23(1):63. doi: 10.4103/jrms.JRMS_904_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghebremariam M.K, Rutten V.P, Vernooij J.C, Uqbazghi K, Tesfaalem T, Butsuamlak T, Idris A.M, Nielen M, Michel A.L. Prevalence and risk factors of bovine tuberculosis in dairy cattle in Eritrea. BMC Vet. Res. 2016;12(1):80. doi: 10.1186/s12917-016-0705-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghielmetti G, Landolt P, Friedel U, Morach M, Hartnack S, Stephan R, Schmitt S. Evaluation of three commercial interferon-γ assays in a bovine tuberculosis free population. Front Vet Sci. 2021;8:682466. doi: 10.3389/fvets.2021.682466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gong Q.L, Chen Y, Tian T, Wen X, Li D, Song Y.H, Wang Q, Du R, Zhang X.X. Prevalence of bovine tuberculosis in dairy cattle in China during 2010-2019: a systematic review and meta-analysis. PLoS Negl. Trop. Dis. 2021;15(6):e0009502. doi: 10.1371/journal.pntd.0009502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Good M, Bakker D, Duignan A, Collins D.M. The history of in vivo tuberculin testing in bovines: tuberculosis, a “One Health” issue. Front. Vet. Sci. 2018;5(1):59. doi: 10.3389/fvets.2018.00059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Good M, Duignan A. Perspectives on the history of bovine TB and the role of tuberculin in bovine TB eradication. Vet. Med. Int. 2011;2011(1):410470. doi: 10.4061/2011/410470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gormley E, Corner L.A.L. Pathogenesis of Mycobacterium bovis infection: the Badger model as a paradigm for understanding tuberculosis in animals. Front. Vet. Sci. 2018;4(1):247. doi: 10.3389/fvets.2017.00247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gortázar C, de la Fuente J, Perelló A, Domínguez L. Will we ever eradicate animal tuberculosis? Ir. Vet. J. 2023;76(1):24. doi: 10.1186/s13620-023-00254-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guallar-Garrido S, Julián E. Bacillus calmette-guérin (BCG) therapy for bladder cancer: an update. Immunotargets. Ther. 2020;9(1):1–11. doi: 10.2147/ITT.S202006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hanif S.N, Garcia-Contreras L. Pharmaceutical aerosols for the treatment and prevention of tuberculosis. Front. Cell. Infect. Microbiol. 2012;2(1):118. doi: 10.3389/fcimb.2012.00118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herrera-Rodríguez S.E, Gordiano-Hidalgo M.A, López-Rincón G, Bojorquez-Narváez L, Padilla-Ramírez F.J, Pereira-Suárez A.L, Flores-Valdez M.A, Estrada-Chávez C. Mycobacterium bovis DNA detection in colostrum as a potential indicator of vaccination effectiveness against bovine tuberculosis. Clin. Vaccine Immunol. 2013;20(4):627–633. doi: 10.1128/CVI.00566-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hope J.C, Thom M.L, Villarreal-Ramos B, Vordermeier H.M, Hewinson R.G, Howard C.J. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin. Exp. Immunol. 2005;139(1):48–56. doi: 10.1111/j.1365-2249.2005.02668.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hossain M.M, Norazmi M.N. Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection—the double-edged sword? Biomed. Res. Int. 2013;2013(1):179174. doi: 10.1155/2013/179174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Houben R.M, Dodd P.J. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10):e1002152. doi: 10.1371/journal.pmed.1002152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Humblet M.F, Boschiroli M.L, Saegerman C. Classification of worldwide bovine tuberculosis risk factors in cattle: a stratified approach. Vet. Res. 2009;40(5):50. doi: 10.1051/vetres/2009033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Islam M.N, Khan M.K, Khan M.F.R, Kostoulas P, Rahman A.K.M.A, Alam M.M. Risk factors and true prevalence of bovine tuberculosis in Bangladesh. PLoS One. 2021;16(2):e0247838. doi: 10.1371/journal.pone.0247838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jemal A.M. Review on zoonotic importance of bovine tuberculosis and its control. Open Access Libr. J. 2016;3(1):e2504. [Google Scholar]
- Kapalamula T.F, Kawonga F, Shawa M, Chizimu J, Thapa J, Nyenje M.E, Mkakosya R.S, Hayashida K, Gordon S, Nakajima C, Munyeme M, Hang’ombe B.M, Suzuki Y. Prevalence and risk factors of bovine tuberculosis in slaughtered cattle, Malawi. Heliyon. 2013;9(2):e13647. doi: 10.1016/j.heliyon.2023.e13647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kasir D, Osman N, Awik A, El Ratel I, Rafei R, Al Kassaa I, El Safadi D, Salma R, El Omari K, Cummings K.J, Kassem I.I, Osman M. Zoonotic tuberculosis: a neglected disease in the middle East and North Africa (MENA) Region. Diseases. 2023;11(1):39. doi: 10.3390/diseases11010039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kawka M, Płocińska R, Płociński P, Pawełczyk J, Słomka M, Gatkowska J, Dzitko K, Dziadek B, Dziadek J. The functional response of human monocyte-derived macrophages to serum amyloid A and Mycobacterium tuberculosis infection. Front. Immunol. 2023;14(1):1238132. doi: 10.3389/fimmu.2023.1238132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kazwala R.R, Kambarage D.M, Daborn C.J, Nyange J, Jiwa S.F, Sharp J.M. Risk factors associated with the occurrence of bovine tuberculosis in cattle in the Southern Highlands of Tanzania. Vet. Res. Commun. 2001;25(8):609–614. doi: 10.1023/a:1012757011524. [DOI] [PubMed] [Google Scholar]
- Keating L.A, Wheeler P.R, Mansoor H, Inwald J.K, Dale J, Hewinson R.G, Gordon S.V. The pyruvate requirement of some members of the Mycobacterium tuberculosis complex is due to an inactive pyruvate kinase: implications for in vivo growth. Mol. Microbiol. 2005;56(1):163–174. doi: 10.1111/j.1365-2958.2005.04524.x. [DOI] [PubMed] [Google Scholar]
- Kemal J, Sibhat B, Abraham A, Terefe Y, Tulu K.T, Welay K, Getahun N. Bovine tuberculosis in eastern Ethiopia: prevalence, risk factors and its public health importance. BMC Infect. Dis. 2019;19(1):39. doi: 10.1186/s12879-018-3628-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krajewska-Wędzina M, Radulski Ł, Waters W.R, Didkowska A, Zabost A, Augustynowicz-Kopeć E, Brzezińska S, Weiner M. Mycobacterium bovis transmission between cattle and a farmer in Central Poland. Pathogens. 2022;11(10):1170. doi: 10.3390/pathogens11101170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lema A.G, Dame I.E. Bovine tuberculosis remains a major public health concern: a review. Austin J. Vet. Sci. Anim. Husb. 2022;9(1):1085. [Google Scholar]
- Little R.A. Negotiated management strategies for bovine tuberculosis: enhancing risk mitigation in Michigan and the UK. Front. Vet. Sci. 2019;6(1):81. doi: 10.3389/fvets.2019.00081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luciano S.A, Roess A. Human zoonotic tuberculosis and livestock exposure in low- and middle-income countries: a systematic review identifying challenges in laboratory diagnosis. Zoonoses Public Health. 2020;67(2):97–111. doi: 10.1111/zph.12684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maitra A, Munshi T, Healy J, Martin L.T, Vollmer W, Keep N.H, Bhakta S. Cell wall peptidoglycan in Mycobacterium tuberculosis: an Achilles’ heel for the TB-causing pathogen. FEMS Microbiol. Rev. 2019;43(5):548–575. doi: 10.1093/femsre/fuz016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malama S, Muma J.B, Godfroid J. A review of tuberculosis at the wildlife-livestock-human interface in Zambia. Infect. Dis. Poverty. 2013;2(1):13. doi: 10.1186/2049-9957-2-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malikowski T, Mahmood M, Smyrk T, Raffals L, Nehra V. Tuberculosis of the gastrointestinal tract and associated viscera. J. Clin. Tuberc. Other Mycobact. Dis. 2018;12(1):1–8. doi: 10.1016/j.jctube.2018.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mandal P.K, Ahsan M.I, Apu H.D, Akter S, Ahmed S.S.U, Paul S. Very low prevalence of bovine tuberculosis in cattle in Sylhet district of Bangladesh. Heliyon. 2023;9(12):e22756. doi: 10.1016/j.heliyon.2023.e22756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maphasa R.E, Meyer M, Dube A. The macrophage response to Mycobacterium tuberculosis and opportunities for autophagy inducing nanomedicines for tuberculosis therapy. Front. Cell. Infect. Microbiol. 2021;10(1):618414. doi: 10.3389/fcimb.2020.618414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mayahi M, Mosavari N, Esmaeilzadeh S, Parvandar-Asadollahi K. Comparison of four different culture media for growth of Mycobacterium avium subsp. avium isolated from naturally infected lofts of domestic pigeons. Iran. J. Microbiol. 2013;5(4):379–382. [PMC free article] [PubMed] [Google Scholar]
- Meiring C, van Helden P.D, Goosen W.J. TB control in humans and animals in South Africa: a perspective on problems and successes. Front. Vet. Sci. 2018;5(1):298. doi: 10.3389/fvets.2018.00298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mekonnen G.A, Conlan A.J.K, Berg S, Ayele B.T, Alemu A, Guta S, Lakew M, Tadesse B, Gebre S, Wood J.L.N, Ameni G. Prevalence of bovine tuberculosis and its associated risk factors in the emerging dairy belts of regional cities in Ethiopia. Prev. Vet. Med. 2019;168(1):81–89. doi: 10.1016/j.prevetmed.2019.04.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Menin Á, Fleith R, Reck C, Marlow M, Fernandes P, Pilati C, Báfica A. Asymptomatic cattle naturally infected with Mycobacterium bovis present exacerbated tissue pathology and bacterial dissemination. PLoS One. 2013;8(1):e53884. doi: 10.1371/journal.pone.0053884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mia M.M, Hasan M, Pory F.S. Occupational exposure to livestock and risk of tuberculosis and brucellosis: a systematic review and meta-analysis. One Health. 2022;15(1):100432. doi: 10.1016/j.onehlt.2022.100432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mishra A, Singhal A, Chauhan D.S, Katoch V.M, Srivastava K, Thakral S.S, Bharadwaj S.S, Sreenivas V, Prasad H.K. Direct detection and identification of Mycobacterium tuberculosis and Mycobacterium bovis in bovine samples by a novel nested PCR assay: correlation with conventional techniques. J. Clin. Microbiol. 2005;43(11):5670–5678. doi: 10.1128/JCM.43.11.5670-5678.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mitermite M, Elizari J.M.U, Ma R, Farrell D, Gordon S.V. Exploring virulence in Mycobacterium bovis: clues from comparative genomics and perspectives for the future. Ir. Vet. J. 2023;76(Suppl 1):26. doi: 10.1186/s13620-023-00257-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mohamed A. Bovine tuberculosis at the human-livestock-wildlife interface and its control through one health approach in the Ethiopian Somali pastoralists: a review. One Health. 2019;9(1):100113. doi: 10.1016/j.onehlt.2019.100113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Müller B, Dürr S, Alonso S, Hattendorf J, Laisse C.J, Parsons S.D, van Helden P.D, Zinsstag J. Zoonotic Mycobacterium bovis-induced tuberculosis in humans. Emerg. Infect. Dis. 2013;19(6):899–908. doi: 10.3201/eid1906.120543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Napp S, Allepuz A, Mercader I, Nofrarías M, López-Soria S, Domingo M, Romero B, Bezos J, de Val BP. Evidence of goats acting as domestic reservoirs of bovine tuberculosis. Vet. Rec. 2013;172(25):663. doi: 10.1136/vr.101347. [DOI] [PubMed] [Google Scholar]
- Nava-Vargas A, Milián-Suazo F, Cantó-Alarcón G.J, Gutiérrez-Pabello J.A. Intracellular survival of Mycobacterium bovis strains with high and low frequency in cattle populations in a bovine macrophage model. Rev. Mex. Cienc. Pecu. 2021;12(2):487–502. [Google Scholar]
- O’Halloran C, Ioannidi O, Reed N, Murtagh K, Dettemering E, Van Poucke S, Gale J, Vickers J, Burr P, Gascoyne-Binzi D, Howe R, Dobromylskyj M, Mitchell J, Hope J, Gunn-Moore D. Tuberculosis due to Mycobacterium bovis in pet cats associated with feeding a commercial raw food diet. J. Feline Med. Surg. 2019;21(8):667–681. doi: 10.1177/1098612X19848455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O’Brien D.J, Thacker T.C, Salvador L.C.M, Duffiney A.G, Robbe-Austerman S, Camacho M.S, Lombard J.E, Palmer M.V. The devil you know and the devil you don’t: current status and challenges of bovine tuberculosis eradication in the United States. Ir. Vet. J. 2023;76(Suppl 1):16. doi: 10.1186/s13620-023-00247-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O’Connor C.M, Abid M, Walsh A.L, Behbod B, Roberts T, Booth L.V, Thomas H.L, Smith N.H, Palkopoulou E, Dale J, Nunez-Garcia J, Morgan D. Cat-to-human transmission of Mycobacterium bovis, United Kingdom. Emerg. Infect. Dis. 2019;25(12):2284–2286. doi: 10.3201/eid2512.190012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Olea-Popelka F, Muwonge A, Perera A, Dean A.S, Mumford E, Erlacher-Vindel E, Forcella S, Silk B.J, Ditiu L, El Idrissi A, Raviglione M, Cosivi O, LoBue P, Fujiwara P.I. Zoonotic tuberculosis in human beings caused by Mycobacterium bovis-a call for action. Lancet Infect. Dis. 2017;17(1):e21–e25. doi: 10.1016/S1473-3099(16)30139-6. [DOI] [PubMed] [Google Scholar]
- Ortiz A.P, Perea C, Davalos E, Velázquez E.F, González K.S, Camacho E.R, Latorre E.A.G, Lara C.S, Salazar R.M, Bravo D.M, Stuber T.P, Thacker T.C, Robbe-Austerman S. Whole genome sequencing links Mycobacterium bovis from cattle, cheese and humans in Baja California, Mexico. Front. Vet. Sci. 2021;8(1):674307. doi: 10.3389/fvets.2021.674307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pal M, Tolawak D, Bikila U. Zoonotic importance of bovine tuberculosis in Ethiopia: an overview. Res. Vet. Sci. Med. 2022;2(7):1–5. [Google Scholar]
- Palmer M.V, Waters W.R. Bovine tuberculosis and the establishment of an eradication program in the United States: role of veterinarians. Vet. Med. Int. 2011;2011(1):816345. doi: 10.4061/2011/816345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palmer M.V, Kanipe C, Boggiatto P.M. The bovine tuberculoid granuloma. Pathogens. 2022;11(1):61. doi: 10.3390/pathogens11010061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palmer M.V, Thacker T.C, Waters W.R, Gortázar C, Corner L.A. Mycobacterium bovis: a model pathogen at the interface of livestock, wildlife, and humans. Vet. Med. Int. 2012;2012(1):236205. doi: 10.1155/2012/236205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pérez-Morote R, Pontones-Rosa C, Gortázar-Schmidt C, Muñoz-Cardona Á.I. Quantifying the economic impact of bovine tuberculosis on livestock farms in South-Western Spain. Animals (Basel) 2020;10(12):2433. doi: 10.3390/ani10122433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Phillips C.J, Foster C.R, Morris P.A, Teverson R. The transmission of Mycobacterium bovis infection to cattle. Res. Vet. Sci. 2003;74(1):1–15. doi: 10.1016/s0034-5288(02)00145-5. [DOI] [PubMed] [Google Scholar]
- Phipps E, McPhedran K, Edwards D, Russell K, O’Connor C.M, Gunn-Moore D.A, O’Halloran C, Roberts T, Morris J. Bovine tuberculosis in working foxhounds: lessons learned from a complex public health investigation. Epidemiol. Infect. 2018;147(1):e24. doi: 10.1017/S0950268818002753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pokam B.D.T, Guemdjom P.W, Yeboah-Manu D, Weledji E.P, Enoh J.E, Tebid P.G, Asuquo A.E. Challenges of bovine tuberculosis control and genetic distribution in Africa. Biomed. Biotechnol. Res. J. 2019;3(4):217–227. [Google Scholar]
- Rahlwes K.C, Dias B.R.S, Campos P.C, Alvarez-Arguedas S, Shiloh M.U. Pathogenicity and virulence of Mycobacterium tuberculosis. Virulence. 2023;14(1):2150449. doi: 10.1080/21505594.2022.2150449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rahman M.T, Sobur M.A, Islam M.S, Ievy S, Hossain M.J, El Zowalaty M.E, Rahman A.T, Ashour H.M. Zoonotic diseases: etiology, impact, and control. Microorganisms. 2020;8(9):1405. doi: 10.3390/microorganisms8091405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramanujam H, Palaniyandi K. Bovine tuberculosis in India: the need for one Health approach and the way forward. One Health. 2023;16(1):100495. doi: 10.1016/j.onehlt.2023.100495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramos B, Pereira A.C, Reis A.C, Cunha M.V. Estimates of the global and continental burden of animal tuberculosis in key livestock species worldwide: a meta-analysis study. One Health. 2020;10(1):100169. doi: 10.1016/j.onehlt.2020.100169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramos D.F, Silva P.E.A, Dellagostin O.A. Diagnosis of bovine tuberculosis: review of main techniques. Braz. J. Biol. 2015;75(4):830–837. doi: 10.1590/1519-6984.23613. [DOI] [PubMed] [Google Scholar]
- Rana S.S, Bhasin D.K, Rao C, Srinivasan R, Singh K. Tuberculosis presenting as dysphagia: clinical, endoscopic, radiological and endosonographic features. Endosc Ultrasound. 2013;2(2):92–95. doi: 10.4103/2303-9027.117693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Renwick A.R, White P.C, Bengis R.G. Bovine tuberculosis in southern African wildlife: a multi-species host-pathogen system. Epidemiol. Infect. 2007;135(4):529–540. doi: 10.1017/S0950268806007205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robinson P.A. Performativity and a microbe: exploring Mycobacterium bovis and the political ecologies of bovine tuberculosis. Biosocieties. 2019;14(2):179–204. doi: 10.1057/s41292-018-0124-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodrigues D.L, Amorim E.A, Ferreira F, Amaku M, Baquero O.S, de Hildebrand E Grisi Filho J.H, Dias R.A, Heinemann M.B, Telles E.O, Gonçalves V.S.P, Compton C, Ferreira Neto J.S. Apparent prevalence and risk factors for bovine tuberculosis in the state of Paraná, Brazil: an assessment after 18 years since the beginning of the Brazilian program. Trop. Anim. Health Prod. 2022;54(6):360. doi: 10.1007/s11250-022-03350-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sakamoto S, Putalun W, Vimolmangkang S, Phoolcharoen W, Shoyama Y, Tanaka H, Morimoto S. Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites. J. Nat. Med. 2018;72(1):32–42. doi: 10.1007/s11418-017-1144-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandhu G.K. Tuberculosis: current situation, challenges and overview of its control programs in India. J. Glob. Infect. Dis. 2011;3(2):143–150. doi: 10.4103/0974-777X.81691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Santos E, Fehlberg I, Fernandes B, de Alcântara A, Silva B, Cerqueira R. Detection of Mycobacterium sp. by multiplex PCR directly from suspicious granulomas from cold chambers in the state of Bahia, Brazil. Arq. Inst. Biol. 2020;88(1):1–8. [Google Scholar]
- Sharma S.K, Mohan A, Sharma A. Miliary tuberculosis: a new look at an old foe. J. Clin. Tuberc. Other Mycobact. Dis. 2016;3(1):13–27. doi: 10.1016/j.jctube.2016.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sichewo P.R, Kelen C.V, Thys S, Michel A.L. Risk practices for bovine tuberculosis transmission to cattle and livestock farming communities living at wildlife-livestock-human interface in northern KwaZulu Natal, South Africa. PLoS Negl. Trop. Dis. 2020;14(3):e0007618. doi: 10.1371/journal.pntd.0007618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silva M.R, Ada S.R, da Costa R.R, de Alencar A.P, de Oliveira V.M, Júnior A.A.F, Sales M.L, Mde A.I, Filho P.M, Pereira O.T, dos Santos E.C, Mendes R.S, Ferreira A.M, Mota P.M, Suffys P.N, Guimarães M.D. Tuberculosis patients co-infected with Mycobacterium bovis and Mycobacterium tuberculosis in an urban area of Brazil. Mem. Inst. Oswaldo Cruz. 2013;108(3):321–327. doi: 10.1590/S0074-02762013000300010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Skuce R.A, Allen A.R, McDowell S.W. Herd-level risk factors for bovine tuberculosis: a literature review. Vet. Med. Int. 2012;2012(1):621210. doi: 10.1155/2012/621210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith K, Kleynhans L, Warren R.M, Goosen W.J, Miller M.A. Cell-mediated immunological biomarkers and their diagnostic application in livestock and wildlife infected with Mycobacterium bovis. Front. Immunol. 2021;12(1):639605. doi: 10.3389/fimmu.2021.639605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spositto F.L, Campanerut P.A, Ghiraldi L.D, Leite C.Q, Hirata M.H, Hirata R.D, Siqueira V.L, Cardoso R.F. Multiplex-PCR for differentiation of Mycobacterium bovis from Mycobacterium tuberculosis complex. Braz. J. Microbiol. 2014;45(3):841–3. doi: 10.1590/s1517-83822014000300012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Srinivasan S, Conlan A.J.K, Easterling L.A, Herrera C, Dandapat P, Veerasami M, Ameni G, Jindal N, Raj G.D, Wood J, Juleff N, Bakker D, Vordermeier M, Kapur V. A. Meta-analysis of the effect of Bacillus calmette-guérin vaccination against bovine tuberculosis: is perfect the enemy of good? Front. Vet. Sci. 2021;8:637580. doi: 10.3389/fvets.2021.637580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sumanth L.J, Suresh C.R, Venkatesan M, Manesh A, Behr M.A, Kapur V, Michael J.S. Clinical features of human tuberculosis due to Mycobacterium orygis in Southern India. J. Clin. Tuberc. Other Mycobact. Dis. 2023;32(1):100372. doi: 10.1016/j.jctube.2023.100372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tora E, Getachew M, Seyoum W, Abayneh E. Public awareness, prevalence and potential determinants of bovine tuberculosis in selected districts of gamo zone, Southern Ethiopia. Vet. Med. (Auckl) 2022;13(1):163–172. doi: 10.2147/VMRR.S370733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Toribio J.L.M.L, Lomata K, Fullman S, Jenkins A, Borja E, Arif S, McKercher J, Blake D, Garcia A, Whittington R.J, Underwood F, Marais B.J. Assessing risks for bovine and zoonotic tuberculosis through spatial analysis and a questionnaire survey in Fiji – A pilot study. Heliyon. 2023;9(12):e22776. doi: 10.1016/j.heliyon.2023.e22776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Torres-Gonzalez P, Cervera-Hernandez M.E, Martinez-Gamboa A, Garcia-Garcia L, Cruz-Hervert L.P, Valle M.B.D, Leon A.P, Sifuentes-Osornio J. Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000-2015. BMC Infect. Dis. 2016;16(1):657. doi: 10.1186/s12879-016-2001-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tschopp R, Conlan A.J.K, Gemechu G, Almaw G, Hattendorf J, Zinsstag J, Wood J.L.N. Effect of bovine tuberculosis on selected productivity parameters and trading in dairy cattle kept under intensive husbandry in central ethiopia. Front. Vet. Sci. 2021;8(1):698768. doi: 10.3389/fvets.2021.698768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tschopp R, Schelling E, Hattendorf J, Aseffa A, Zinsstag J. Risk factors of bovine tuberculosis in cattle in rural livestock production systems of Ethiopia. Prev. Vet. Med. 2009;89(3–4):205–211. doi: 10.1016/j.prevetmed.2009.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tulu B, Zewede A, Belay M, Zeleke M, Girma M, Tegegn M, Ibrahim F, Jolliffe D.A, Abebe M, Balcha T.T, Gumi B, Martineau H.M, Martineau A.R, Ameni G. Epidemiology of bovine tuberculosis and its zoonotic implication in addis Ababa Milkshed, Central Ethiopia. Front. Vet. Sci. 2021;8(1):595511. doi: 10.3389/fvets.2021.595511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vordermeier M, Ameni G, Berg S, Bishop R, Robertson B.D, Aseffa A, Hewinson R.G, Young D.B. The influence of cattle breed on susceptibility to bovine tuberculosis in Ethiopia. Comp. Immunol. Microbiol. Infect. Dis. 2012;35(3):227–232. doi: 10.1016/j.cimid.2012.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waritani T, Chang J, McKinney B, Terato K. An ELISA protocol to improve the accuracy and reliability of serological antibody assays. MethodsX. 2017;4(1):153–165. doi: 10.1016/j.mex.2017.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waters W.R, Palmer M.V. Mycobacterium bovis infection of cattle and white-tailed deer: translational research of relevance to human tuberculosis. ILAR J. 2015;56(1):26–43. doi: 10.1093/ilar/ilv001. [DOI] [PubMed] [Google Scholar]
- Weiss G, Schaible U.E. Macrophage defense mechanisms against intracellular bacteria. Immunol. Rev. 2015;264(1):182–203. doi: 10.1111/imr.12266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiker H.G. MPB70 and MPB83--major antigens of Mycobacterium bovis. Scand. J. Immunol. 2009;69(6):492–499. doi: 10.1111/j.1365-3083.2009.02256.x. [DOI] [PubMed] [Google Scholar]
- Yatbantoong N, Rukkwamsuk T. A review: diagnosis of bovine tuberculosis. J. Kasetsart Vet. 2017;27(2):103–127. [Google Scholar]
- Zhai W, Wu F, Zhang Y, Fu Y, Liu Z. The immune escape mechanisms of Mycobacterium Tuberculosis. Int. J. Mol. Sci. 2019;20(2):340. doi: 10.3390/ijms20020340. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All references are open access, so data can be obtained from the online web.